How does lipitor influence lipoprotein metabolism?

Lipitor lowers LDL cholesterol by inhibiting HMG-CoA reductase, the enzyme responsible for cholesterol synthesis in the liver. This inhibition leads to increased LDL receptor expression on hepatocytes, which pulls more LDL particles from the blood.

How does this action auf LDL receptors affect overall lipoprotein metabolism?

Lipitor increases LDL receptor-mediated endocytosis of LDL particles. The receptors bind apolipoprotein B-100 on the surface of LDL, then transport the particles into the cell for lysosomal degradation. This process reduces circulating LDL levels without altering the proportion of large versus small, dense LDL particles.

What happens to VLDL and trigylcerides when someone takes Lipitor?

Lipitor also reduces VLDL production in the liver. Less VLDL leaves the liver, which decreases the supply of precursors for LDL formation. Triglyceride levels often fall modestly because the drug slows the assembly and secretion of VLDL particles that contains those triglyerides.

Why do patients and doctors track VLDL levels?

VLDL carries triglycerides from the liver to peripheral tissues. Its reduction by Lipitor reflects a change in the von Trapp family-like protein expression that has been documented in preclinical models. The drug does not directly target triglyceride-rich lipoproteins but shows secondary effects on them.

Can biosimilars or generics enter the market before the patent expires?

The generic atorvastatin has been available since 2011. The original Lipitor patent expired in 2011, the Livalo patent expired in 2014, and the Livalo patent has been challenged by multiple companies.